KMPHARMACEUTICAL Co.,Ltd. (KOSDAQ:225430)
South Korea · Delayed Price · Currency is KRW 1,815.00
+45.00 (2.54%)
At close: Aug 12, 2026
KMPHARMACEUTICAL Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 16,379 | 15,990 | 14,475 | 17,770 | 15,631 | 22,705 |
Revenue Growth | 16.27% | 10.47% | -18.54% | 13.68% | -31.16% | -0.97% |
Gross Profit Gross Profit Growth | 3,907 | 3,838 | 3,606 | 4,910 | 3,225 | 5,663 |
Operating Income Operating Income Growth | -3,700 | -3,552 | -3,848 | -1,113 | -3,722 | 866.14 |
Net Income Net Income Growth | -3,978 | -3,968 | -4,573 | -1,320 | -3,925 | -611.19 |
Earnings Per Share EPS Growth | -142.12 | -142.29 | -164.00 | -47.00 | -141.00 | -22.00 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Household Goods and Quasi-drugs Product Household Goods and Quasi-drugs Product Growth | 13,679 | 16,686 | 14,967 | 22,069 | 21,606 |
Household Goods and Quasi-drugs Merchandise Household Goods and Quasi-drugs Merchandise Growth | 383.04 | 361.36 | 254.52 | 373.02 | 1,149 |
Toll Processing Toll Processing Growth | 23.19 | - | - | - | - |
Other Other Growth | 389.41 | 721.87 | 410.36 | 263.09 | 172.21 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 12.37 | 350.62 | 809.97 | 1,024 | 597.75 | 2,697 |
Total Debt Total Debt Growth | 17,128 | 15,800 | 14,136 | 12,447 | 13,268 | 9,681 |
Net Cash (Debt) Net Cash Growth | -17,115 | -15,449 | -13,326 | -11,423 | -12,671 | -6,985 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -611.49 | -554.00 | -477.87 | -406.72 | -455.17 | -251.42 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -3,134 | -1,751 | -2,036 | 1,446 | -93.32 | 2,267 |
Capital Expenditures CapEx Growth | -524.71 | -258.11 | -365.1 | -112.77 | -57.69 | -2,365 |
Free Cash Flow Free Cash Flow Growth | -3,659 | -2,009 | -2,401 | 1,333 | -151.02 | -97.92 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 23.85% | 24.00% | 24.91% | 27.63% | 20.63% | 24.94% |
Operating Margin | -22.59% | -22.21% | -26.58% | -6.26% | -23.81% | 3.82% |
Pretax Margin | -23.77% | -24.29% | -29.36% | -5.42% | -29.26% | -2.26% |
Profit Margin | -24.29% | -24.82% | -31.60% | -7.43% | -25.11% | -2.69% |
FCF Margin | -22.34% | -12.56% | -16.59% | 7.50% | -0.97% | -0.43% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
P/FCF Ratio | - | - | - | 20.45 | - | - |
PS Ratio | 0.60 | 0.94 | 1.32 | 1.54 | 2.84 | 2.73 |